Discover 165 paid clinical trials in Honolulu, Hawaii. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 165
Featured
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
for
Obesity or Overweight
Location: Honolulu HI, Walnut Creek CA, Irvine CA, Portland OR,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351045
Phase 3, Recruiting
Featured
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for
Parkinson's Disease
Location: Honolulu HI, San Francisco CA, Stanford CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07174310
Phase 3, Recruiting
Featured
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
for
Alzheimers Disease
Location: Honolulu HI, Oakland CA, Sherman Oaks CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07177352
Phase 3, Recruiting
Featured
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, c-MET
Location: Honolulu HI, Huntington Beach CA, Lancaster CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT04928846
Phase 3, Recruiting
Featured
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer, c-MET
Location: Honolulu HI, Oxnard CA, Los Angeles CA, Reno NV,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06568939
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Squamous Non-Small Cell Lung Cancer, c-MET
Location: Honolulu HI, Santa Monica CA, Los Angeles CA, Reno NV,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07005102
Phase 2, Phase 3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
for
Advanced Esophageal Adenocarcinoma,
Location: Honolulu HI, ‘Aiea HI, ‘Ewa Beach HI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06203600
Phase 2, Phase 3, Recruiting
Active & Responsive
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
for
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Location: Honolulu HI, ‘Aiea HI, ‘Ewa Beach HI, Santa Rosa CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07018869
Phase 3, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Honolulu HI, Santa Rosa CA, Concord CA, Canoga Park CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase 3, Recruiting
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
for
Obesity, Overweight
Location: Honolulu HI, Walnut Creek CA, Long Beach CA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684235
Phase 3, Recruiting
Active & ResponsiveNew
A Study of COVID-19 Vaccine(s) in Children and Adults
for
COVID-19 Vaccines
Location: Honolulu HI, Salt Lake City UT, Euless TX, Dallas TX,
Sponsor: BioNTech SE
Sex: All
Age: 5+
Code: NCT07798648
Phase 3, Recruiting
Active & ResponsiveNew
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
for
Diabetes Mellitus, Type 2
Location: Honolulu HI, Sacramento CA, Northridge CA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07817251
Phase 3, Recruiting
Active & Responsive
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
for
Overweight, Obesity
Location: Honolulu HI, Indianapolis IN, Lexington KY, Conyers GA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07745504
Phase 3, Recruiting
Active & Responsive
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
for
Overweight, Obesity
Location: Honolulu HI, Corvallis OR, Huntington Park CA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07770841
Phase 3, Recruiting
Active & ResponsiveNew
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
for
Overweight, Obesity
Location: Honolulu HI, Walnut Creek CA, Lomita CA, Fullerton CA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07720271
Phase 3, Recruiting
Active & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for
Obesity, Overweight
Location: Honolulu HI, Sacramento CA, Rolling Hills Estates CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07321886
Phase 3, Recruiting
Active & Responsive
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
for
Epilepsy, Healthy Volunteer
Location: Honolulu HI, Tucson AZ, Cypress TX, Farmington Hills MI,
Sponsor: Suninflam Inc
Sex: All
Age: 18 - 70
Code: NCT07051629
Phase 1, Recruiting
Active & Responsive
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care